Received Aug 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
TE VARVAX administered on 08/13/2025. Confirmed not symptomatic. Supported outcome provided. No additional AE; TE VARVAX administered on 08/13/2025. Confirmed not symptomatic. Supported outcome provided. No additional AE; This spontaneous report was received from an Other health professional and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 13-Aug-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y019318, expiration date: 21-Nov-2026) for prophylaxis. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # not reported). It was reported that the suspect vaccine was underwent temperature excursions of minus 11.7 degree Celsius (C) (the time frame was 31 minutes) (product storage error). There were no previous temperature excursions. Confirmed not symptomatic (no adverse event).
sterile diluent